References in periodicals archive ?
meningitidis was obtained from mother's vagina and also from nasopharynx in both parents, who were completely asymptomatic but vaccinated with the tetravalent meningococcal conjugate vaccine (MCV4) afterwards, and also each parent received a single dose of 125 mgs of intramuscular ceftriaxone.
Students entering the seventh and twelfth grades in West Virginia for the 2015-2016 school year must show proof of age-appropriate Tdap (tetanus, diphtheria and pertussis) and MCV4 (meningitis) vaccinations.
With the widespread use of quadrivalent meningococcal vaccines (MCV4), meningococcal meningitis has declined markedly in all age groups.
Pfizer, a biopharmaceutical company, has reported positive top-line results from a Phase II trial of Trumenba (Meningococcal Group B Vaccine) co-administered with routine meningococcal (A, C, Y, and W) (MCV4) and single-dose tetanus, diptheria and pertussis (Tdap) vaccines It was reported yesterday.
* Use meningococcal vaccine (MCV4) for all patients older than 2 months of age.
"With the expanded indication for this MCV4 vaccine, we now have the opportunity to help protect our infants against four strains of meningococcal disease earlier, when they are most vulnerable."
TravelSafe Clinic, India now offers the latest MCV4 vaccine (Menactra) at all its centers in Chandigarh, Delhi & Mumbai.
According to the CDC, vaccination rates have been rising for tetanus-diphtheria (Tdap) and meningococcal-conjugate vaccine (MCV4).
They focused on three vaccines routinely given in adolescence: Tdap, which guards against tetanus, diphtheria, and acellular pertussis; the meningococcal conjugate vaccine, or MCV4; and the vaccine that protects against HPV.
--Quadrivalent meningococcal conjugate vaccine (MCV4) purple bar has been extended to reflect licensure of MCV4-D (Menactra) use in children as young as age 9 months.
(102) The additional diseases are hepatitis B, hemophilum influenza type b (Hib), varicella (chicken pox), rotavirus, human papillomavirus (HPV), hepatitis A (HAV), meningococcal vaccines (MCV4 and MPSV4), and pneumococcal conjugate (PCV7).
'As the proportion of children receiving MCV4 continues to increase, we expect additional reductions in the incidence of meningococcal disease," the investigators said.